A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

NCT00168896 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

286

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Carboplatin plus Irinotecan vs Carboplatin plus Etoposide

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]
[object Object]